Tai chi exercise for patients with cardiovascular conditions and risk factors: A SYSTEMATIC REVIEW.
Tai chi exercise for patients with cardiovascular conditions and risk factors: A SYSTEMATIC REVIEW.
复制标题
DOI：
10.1097/hcr.0b013e3181a33379
复制
发表时间：
2009-05
影响因子：
3.8
通讯作者：
Phillips R
中科院分区：
文献类型：
--
作者：
Yeh GY;Wang C;Wayne PM;Phillips R
对评价太极拳运动作为心血管疾病（CVD）或心血管危险因素（CVRF）患者干预措施的文献进行系统综述。我们搜索：1）Medline、CAB Alt Health Watch、BIOSIS previews、Science Citation Index、EMBASE和Social Science Citation Index（从开始到2007年10月）; 2）中国医学数据库、中国医院知识、中国国家知识基础设施和中国传统中医药数据库（从开始到2005年6月）; 3）在北京和南京大学的医学图书馆进行手工检索。纳入了以英文和中文发表的临床研究，包括确诊CVD或CVRF的受试者。以标准化方式提取数据; 2名独立研究者评估方法学质量，包括随机对照试验（RCT）的Jadad评分。29项研究符合入选标准：9项RCT、14项非随机研究（NRS）和6项观察性试验（OBS）。3项研究检查了冠心病受试者，5项研究检查了心力衰竭受试者，10项研究检查了包括CVD受试者在内的异质人群。11项研究检查了CVRF受试者（高血压、血脂异常、糖代谢受损）。研究持续时间范围为8周至3年。大多数研究包括<100名受试者（范围5-207）。9项RCT中有6项质量合格（Jadad ≥3）。大多数研究报告太极拳的改善，包括血压降低和运动能力的增加。未报告不良反应。初步证据表明，太极拳运动可能是一种有益的治疗CVD和CVRF的一些患者。需要进一步研究。
To conduct a systematic review of the literature evaluating tai chi exercise as an intervention for patients with cardiovascular disease (CVD) or with cardiovascular risk factors (CVRF). We searched: 1) Medline, CAB Alt Health Watch, BIOSIS previews, Science Citation Index, EMBASE, and Social Science Citation Index from inception through October 2007; 2) Chinese Medical Database, China Hospital Knowledge, China National Knowledge Infrastructure, and China Traditional Chinese Medicine Database from inception through June 2005; and 3) performed hand searches at the medical libraries of Beijing and Nanjing Universities. Clinical studies published in English and Chinese including participants with established CVD or CVRF were included. Data were extracted in a standardized manner; 2 independent investigators assessed methodological quality, including the Jadad score for randomized controlled trials (RCT). Twenty-nine studies met inclusion criteria: 9 RCT, 14 non-randomized studies (NRS), and 6 observational trials (OBS). Three studies examined subjects with coronary heart disease, 5 in heart failure, and 10 in heterogeneous populations that included those with CVD. Eleven studies examined subjects with CVRF (hypertension, dyslipidemia, impaired glucose metabolism). Study duration ranged from 8 weeks to 3 years. Most studies included <100 subjects (range 5–207). Six of nine RCTs were of adequate quality (Jadad ≥3). Most studies report improvements with tai chi, including blood pressure reductions and increases in exercise capacity. No adverse effects were reported. Preliminary evidence suggests that tai chi exercise may be a beneficial adjunctive therapy for some patients with CVD and CVRF. Further research is needed.